-
Track & Monitor
Merger & Acquisition Trends in Pharma - Q1 2026
This report analyzes the merger and acquisition (M&A) activity in Q1 2026 in the Pharma sector.
-
Sector Analysis
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026: Pre-Conference Coverage
ESCMID Global is the annual congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (formerly ECCMID). The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Annual Meeting 2026 will take place in Munich, Germany, between April 17 Â and 21. In advance of the confernece, GlobalData highlighted highly anticipated and noteworthy abstracts in this Pre-Conference Coverage report.
-
CRO Activity and Intel Report, 2025
This report offers an in-depth analysis of the contract research organization (CRO) industry, categorized by geography, therapeutic area, and phase of development for 2025. This report offers an in-depth analysis of the contract research organization (CRO) industry, categorized by geography, therapeutic area, and phase of development for Q2 2025.
-
Sector Analysis
Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape
Report Value Proposition – Why This Matters for You The thyroid cancer therapeutics market continues to evolve as targeted therapies become increasingly integrated into standard treatment protocols for advanced disease management. In parallel, immunotherapies are emerging as promising experimental approaches for selected patient populations, while late-stage pipeline development continues to reshape the future competitive landscape. This report helps you understand how epidemiology trends, treatment innovation, pipeline development, and strategic industry activity are shaping the global thyroid cancer therapeutics market. In...
-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, March 2026
Stay Ahead in the Pharmaceutical Outsourcing Market The pharmaceutical outsourcing landscape is constantly evolving, shaped by deal activity, regulatory changes, and shifting manufacturing priorities. This monthly report delivers a clear view of the latest developments impacting Contract Manufacturing Organizations (CMOs). It tracks outsourcing contracts, M&A activity, financing deals, and facility-level updates, alongside insights into business conditions and emerging risks. From GMP inspections to site openings and technology investments, the report keeps you informed on what is shaping the outsourcing ecosystem....
-
Sector Analysis
Progressive Pulmonary Fibrosis: Opportunity Assessment, Epidemiology, Disease Management, and Forecast to 2035
Why Does the Progressive Pulmonary Fibrosis Market Matter for Your Business? The progressive pulmonary fibrosis (PPF) therapeutics market is entering a new phase of development, driven by growing diagnosis rates, expanding research activity, and the advancement of late-stage disease-modifying therapies. This report provides a comprehensive analysis of the PPF market across the seven major markets (7MM) — the US, France, Germany, Italy, Spain, the UK, and Japan — including treatment trends, pipeline products, competitive dynamics, unmet needs, and market forecasts...
-
Sector Analysis
Venous Thromboembolism (VTE): Epidemiology Forecast to 2034
Venous thromboembolism (VTE), comprised of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a potentially fatal condition which impedes blood flow by causing blood clots (thrombosis) (Wendelboe et al., 2021). In a VTE, a DVT is a clot that occurs only in the veins; DVT is commonly found in the legs and pelvis (proximally) but can also occur in the upper body (distally) (Henke et al., 2020). If the DVT travels from its original location through the circulatory system...
-
Sector Analysis
Human Immunodeficiency Virus (HIV) Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033
Report Value Proposition – Why This Matters for You The HIV therapeutics market continues to evolve through advances in antiretroviral therapy (ART), long-acting injectable treatments, and pre-exposure prophylaxis (PrEP) innovations. Decades after HIV was first identified as the cause of acquired immunodeficiency syndrome (AIDS), the treatment landscape has become increasingly competitive, with new technologies improving disease management, patient adherence, and long-term outcomes. This report helps you understand how epidemiology trends, treatment innovation, pipeline development, and competitive dynamics are shaping the...
-
Product Insights
Gastric Cancer - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Gastric Cancer - Global Clinical Trials Review, 2026" provides an overview of Gastric Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Gastric Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Eosinophilic Esophagitis - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Eosinophilic Esophagitis - Global Clinical Trials Review, 2026" provides an overview of Eosinophilic Esophagitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Eosinophilic Esophagitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.